Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Cambridge Innovation Capital (Jersey) Limited investment portfolio
Cambridge Innovation Capital (Jersey) Limited has made numerous investments in companies such as Immutrin, Storm Therapeutics, and Riverlane within the Biotech sector.
vc
Portfolio
14
Team
0
Portfolio (14)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Abcodia Limited Abcodia develops biomarker‑based medical tests that detect cancer at an early, asymptomatic stage, providing screening tools for healthcare providers. | Healthcare & Life Sciences | Manchester | Confirmed | 2025-09-22 |
| Congenica Ltd Congenica delivers a Clinical Decision Support platform that enables rapid, accurate analysis and interpretation of genomic data for clinicians and diagnostic laboratories, supporting national genomic medicine programmes such as the NHS and Genomics England. | Healthcare & Life Sciences | Cambridge | Confirmed | 2025-10-30 |
Backs Similar Companies
Investors who tend to invest in the same sort of companies.
5 more similar investors hiddenSign up to unlock →
Shareholding changes (12)
Cambridge Innovation Capital (Jersey) Limited's positions across portfolio companies2025
- A ORDINARY 8,230,290 → 0
- C ORDINARY 1,851,852 → 0
- SEED 4,000,000 → 0
- SERIES B 1,080,236 → 0
Articles (2)
- 13 May 2026
- Storm Therapeutics secures £9.2m for clinical stage RNA research9 May 2026Storm Therapeutics